Literature DB >> 25863951

Fluorescence-guided resection with 5-aminolevulinic acid of meningeal sarcoma in a child.

Luis Miguel Bernal García1, José Manuel Cabezudo Artero, Manuel Royano Sánchez, María Bella Marcelo Zamorano, María López Macías.   

Abstract

BACKGROUND: The usefulness of fluorescence-guided resection with 5-aminolevulinic acid for malignant brain gliomas was demonstrated by Stummer. However, there are several articles in the literature showing the usefulness of the technique for other types of tumors, including benign tumors, such as ependymomas or meningiomas. Meningeal sarcomas are rare, highly aggressive malignant tumors, predominately affecting the pediatric population and have a poor prognosis in spite of treatment. Surgical treatment thereof should consist of the most complete resection possible.
METHODS: In this article, we present the case of a seven-year-old boy who received surgical treatment for a left frontal tumor after oral administration of 5-aminolevulinic acid (5-ALA); the definitive histological diagnosis of which was meningeal sarcoma. The technique was useful for achieving a complete resection, as the lesion emitted intense fluorescence, and after resection of the lesion with the usual technique, intraoperative fluorescent spots were observed in the resection bed that were also tumor. Imaging tests performed 5 years after surgery ruled out recurrence of the tumor.
CONCLUSION: To our knowledge, this is the first case published in the literature of meningeal sarcoma in a child in which intraoperative fluorescence with 5-ALA was used to achieve a complete resection.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25863951     DOI: 10.1007/s00381-015-2703-9

Source DB:  PubMed          Journal:  Childs Nerv Syst        ISSN: 0256-7040            Impact factor:   1.475


  21 in total

1.  Intraoperative 5-aminolevulinic-acid-induced fluorescence in meningiomas.

Authors:  Daniel Coluccia; Javier Fandino; Masayuki Fujioka; Susanne Cordovi; Carl Muroi; Hans Landolt
Journal:  Acta Neurochir (Wien)       Date:  2010-06-10       Impact factor: 2.216

2.  Photodynamic diagnosis in surgery for spinal ependymoma. Case illustration.

Authors:  Satoru Shimizu; Satoshi Utsuki; Kimitoshi Sato; Hidehiro Oka; Kiyotaka Fujii; Kimihiko Mii
Journal:  J Neurosurg Spine       Date:  2006-10

3.  Intraoperative detection of malignant gliomas by 5-aminolevulinic acid-induced porphyrin fluorescence.

Authors:  W Stummer; S Stocker; S Wagner; H Stepp; C Fritsch; C Goetz; A E Goetz; R Kiefmann; H J Reulen
Journal:  Neurosurgery       Date:  1998-03       Impact factor: 4.654

4.  Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial.

Authors:  Walter Stummer; Uwe Pichlmeier; Thomas Meinel; Otmar Dieter Wiestler; Friedhelm Zanella; Hans-Jürgen Reulen
Journal:  Lancet Oncol       Date:  2006-05       Impact factor: 41.316

5.  5-Aminolevulinic acid-induced protoporphyrin IX fluorescence in meningioma: qualitative and quantitative measurements in vivo.

Authors:  Pablo A Valdes; Kimon Bekelis; Brent T Harris; Brian C Wilson; Frederic Leblond; Anthony Kim; Nathan E Simmons; Kadir Erkmen; Keith D Paulsen; David W Roberts
Journal:  Neurosurgery       Date:  2014-03       Impact factor: 4.654

6.  Dynamic PET 18F-FDG studies in patients with primary and recurrent soft-tissue sarcomas: impact on diagnosis and correlation with grading.

Authors:  A Dimitrakopoulou-Strauss; L G Strauss; M Schwarzbach; C Burger; T Heichel; F Willeke; G Mechtersheimer; T Lehnert
Journal:  J Nucl Med       Date:  2001-05       Impact factor: 10.057

7.  Quantitative and qualitative 5-aminolevulinic acid-induced protoporphyrin IX fluorescence in skull base meningiomas.

Authors:  Kimon Bekelis; Pablo A Valdés; Kadir Erkmen; Frederic Leblond; Anthony Kim; Brian C Wilson; Brent T Harris; Keith D Paulsen; David W Roberts
Journal:  Neurosurg Focus       Date:  2011-05       Impact factor: 4.047

8.  Use of 5-aminolevulinic acid in fluorescence-guided resection of meningioma with high risk of recurrence. Case report.

Authors:  Yoshinaga Kajimoto; Toshihiko Kuroiwa; Shin-Ichi Miyatake; Tsugumichi Ichioka; Minoru Miyashita; Hidekazu Tanaka; Motomu Tsuji
Journal:  J Neurosurg       Date:  2007-06       Impact factor: 5.115

9.  The impact of fluorescence guidance on spinal intradural tumour surgery.

Authors:  Sven O Eicker; Frank W Floeth; Marcel Kamp; Hans-Jakob Steiger; Daniel Hänggi
Journal:  Eur Spine J       Date:  2013-01-10       Impact factor: 3.134

10.  Predicting the "usefulness" of 5-ALA-derived tumor fluorescence for fluorescence-guided resections in pediatric brain tumors: a European survey.

Authors:  Walter Stummer; Floriano Rodrigues; Philippe Schucht; Matthias Preuss; Dorothee Wiewrodt; Ulf Nestler; Marco Stein; José Manuel Cabezudo Artero; Nunzio Platania; Jane Skjøth-Rasmussen; Alessandro Della Puppa; John Caird; Søren Cortnum; Sam Eljamel; Christian Ewald; Laura González-García; Andrew J Martin; Ante Melada; Aurelia Peraud; Angela Brentrup; Thomas Santarius; Hans Herbert Steiner
Journal:  Acta Neurochir (Wien)       Date:  2014-09-24       Impact factor: 2.216

View more
  4 in total

1.  Undifferentiated meningeal sarcoma of childhood presenting as hard mass adhered to major intracranial vessels.

Authors:  Navneet Singla; Ankur Kapoor; Debajyoti Chatterjee
Journal:  Childs Nerv Syst       Date:  2016-03-03       Impact factor: 1.475

Review 2.  5ALA in pediatric brain tumors is not routinely beneficial.

Authors:  Jonathan Roth; Shlomi Constantini
Journal:  Childs Nerv Syst       Date:  2017-03-14       Impact factor: 1.475

3.  5-ALA fluorescence in randomly selected pediatric brain tumors assessed by spectroscopy and surgical microscope.

Authors:  Peter Milos; Neda Haj-Hosseini; Jan Hillman; Karin Wårdell
Journal:  Acta Neurochir (Wien)       Date:  2022-10-15       Impact factor: 2.816

4.  The use of 5-aminolevulinic acid in resection of pediatric brain tumors: a critical review.

Authors:  Chenran Zhang; Frederick A Boop; John Ruge
Journal:  J Neurooncol       Date:  2018-11-15       Impact factor: 4.130

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.